Cleary Chris 4
4 · Orchestra BioMed Holdings, Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Orchestra BioMed (OBIO) Director Chris Cleary Withholds 676 Shares
What Happened
Chris Cleary, a director of Orchestra BioMed (OBIO), had 676 shares withheld by the company to satisfy tax withholding obligations in connection with vesting restricted stock units. The withholding is reported as a disposition at $3.71 per share, equal to roughly $2,508. This was an administrative tax-withholding action rather than an open-market sale.
Key Details
- Transaction date: 2026-02-05; Form 4 filed: 2026-02-06 (timely filing).
- Reported transaction: 676 shares withheld at $3.71/share; total value reported $2,508.
- Transaction code: F (payment of exercise price or tax liability); footnote states no shares were sold in the market to satisfy withholding.
- Shares owned after the transaction: Not disclosed in the provided filing excerpt.
- Filing accession: 0001104659-26-011533.
Context
This is a routine tax-withholding event tied to RSU vesting and should not be read as an insider selling shares on the open market. Such withholdings are common to cover tax obligations and do not necessarily indicate the insider’s view on the company’s prospects.
Insider Transaction Report
- Tax Payment
Common Stock, par value $0.0001 per share ("Common Stock")
[F1]2026-02-05$3.71/sh−676$2,508→ 36,901 total
Footnotes (1)
- [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.